Ishita Pharmaceuticals, a related party, acquired 125 equity shares (Rs 10 each) of Ishita Drugs & Industries Ltd under SEBI SAST disclosure requirements (Regulation 29(2)).
AI Assistant
Ishita Drugs & Industries Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.